MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 16.03.2026
Oragenics P/S 2011-2026 | OGEN
P/S Jährlich Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 86 | 49.8 | 9.38 | - | - | - | - | - | 32.1 | 30.4 | 104 | 43.3 | 4.95 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 104 | 4.95 | 45 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Anika Therapeutics
ANIK
|
2.24 | $ 14.93 | 0.88 % | $ 219 M |  USA |
 |
Aptorum Group Limited
APM
|
105 | $ 0.93 | 0.51 % | $ 5.07 M |  China |
 |
Aquestive Therapeutics
AQST
|
10.5 | $ 4.14 | 0.36 % | $ 443 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 8.39 | 4.5 % | $ 230 M |  Israel |
 |
Ardelyx
ARDX
|
3.98 | $ 6.06 | 1.94 % | $ 1.46 B | USA |
 |
argenx SE
ARGX
|
311 | $ 749.68 | 0.44 % | $ 25 B |  Niderland |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.93 | 1.27 % | $ 3.04 B | USA |
 |
Arvinas
ARVN
|
3.31 | $ 11.36 | 4.7 % | $ 805 M | USA |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | China |
 |
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 61.99 | 1.57 % | $ 8.29 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B |  France |
 |
Assembly Biosciences
ASMB
|
4.27 | $ 29.09 | 0.28 % | $ 326 M | USA |
 |
Actinium Pharmaceuticals
ATNM
|
343 | $ 1.13 | 15.26 % | $ 35.3 M | USA |
 |
Atossa Therapeutics
ATOS
|
4.2 K | $ 5.19 | -3.36 % | $ 44.7 M | USA |
 |
Atara Biotherapeutics
ATRA
|
0.61 | $ 5.0 | 0.2 % | $ 62.7 M | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
24.1 | $ 16.05 | 2.79 % | $ 2.16 B |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.41 | -0.35 % | $ 375 M | Britain |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Axon Enterprise
AXON
|
19.1 | $ 411.97 | -0.2 % | $ 31.2 B | USA |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.65 | -1.12 % | $ 16.6 M | USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
BioCardia
BCDA
|
57.2 | $ 1.18 | -1.67 % | $ 7.87 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 9.59 | 6.26 % | $ 1.98 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 9.46 | -3.47 % | $ 612 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 56.04 | 0.96 % | $ 10.7 B | USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 91.64 | 0.5 % | $ 27.2 B | Germany |
 |
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | USA |
 |
BioXcel Therapeutics
BTAI
|
24 | $ 1.18 | -0.42 % | $ 14.4 M | USA |
 |
Burford Capital Limited
BUR
|
6.35 | $ 4.5 | 8.57 % | $ 683 M | Britain |